|
⚲
|
| Keyboard |
| Henneman John B III
✚
|
|
|---|---|
| CIK # | 0001187572 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001187572] | |
| 4 | [0001187572] | |
| 5 | [0001187572] | |
| SC 13G | [0001187572] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Henneman John B III | Dynatronics Corp | [2015-07-10] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Anika Therapeutics Inc ANIK
Common Stock
|
2025-06-20 | Grant | 14,164 | $0.00 | |
|
Orthofix International N V OFIX
Common Stock
|
2025-06-18 | Grant | 18,841 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Stock Options (Right to Buy) · derivative
|
2025-06-05 | Grant | 4,185 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2025-06-05 | Grant | 1,045 | $0.00 | |
|
R1 RCM Inc /de RCM
Common Stock
|
2024-11-19 | Disposed to issuer | 87,765 | $14.30 | 1,255,040 |
|
R1 RCM Inc /de RCM
Director Stock Option (right to buy) · derivative
|
2024-11-19 | Disposed to issuer | 515,715 | ||
|
Anika Therapeutics Inc ANIK
Common Stock
|
2024-07-09 | Grant | 5,771 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Common Stock
|
2024-06-20 | Grant | 1,045 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Stock Options (Right to Buy) · derivative
|
2024-06-20 | Grant | 4,185 | $0.00 | |
|
Orthofix International N V OFIX
Common Stock
|
2024-06-18 | Grant | 15,152 | $12.87 | 195,006 |
|
R1 RCM Inc /de RCM
Common Stock
|
2024-05-23 | Grant | 15,651 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Tranche B Warrant · derivative
|
2024-03-13 | Buy | 3,430 | ||
|
Aprea Therapeutics Inc APRE
Common Stock
|
2024-03-13 | Buy | 6,860 | $7.29 | 50,009 |
|
Aprea Therapeutics Inc APRE
Tranche A Warrant · derivative
|
2024-03-13 | Buy | 3,430 | ||
|
Aprea Therapeutics Inc APRE
Common Stock
|
2023-08-23 | Grant | 500 | $0.00 | |
|
Aprea Therapeutics Inc APRE
Stock Options (Right to Buy) · derivative
|
2023-08-23 | Grant | 2,000 | $0.00 | |
|
R1 RCM Inc /de RCM
Common Stock
|
2023-08-08 | Option exercise | 50,000 | $2.61 | 130,500 |
|
R1 RCM Inc /de RCM
Director Stock Option (right to buy) · derivative
|
2023-08-08 | Option exercise | 50,000 | $0.00 | |
|
R1 RCM Inc /de RCM
Common Stock
|
2023-08-08 | Sell | 50,000 | $17.17 | 858,500 |
|
Anika Therapeutics Inc ANIK
Common Stock
|
2023-06-14 | Grant | 6,500 | $0.00 | |
| showing 20 of 191 most recent transactions | |||||